Major Depressive Disorder. Major Depressive Disorder
Conditions
Interventions
Intervention 1: Intervention group: Recipient of 10 mg oral Escitalopram made by Sobhan Pharmaceutical Company (Lextal) as a single daily dose and 400 mg oral Celecoxib made by Tehran Pharmaceutical C
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Having major depressive disorder Range age betweenh 15-55 years Agree to participate in the study
Exclusion criteria
Exclusion criteria: Existence of another psychiatric disorder Presence of heart disease or the presence of serious risk factors for heart disease Presence of renal impairment Antidepressant treatment in the last 6 months Physical disorders that lead to depression (such as hypothyroidism). Pregnancy Drug addiction major depression Perform parallel treatments Withdrawal from continuing to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of major depressive disorder. Timepoint: Before the intervention, 4 weeks and 8 weeks after the intervention. Method of measurement: Hamilton Depression questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment side effect. Timepoint: Every month. Method of measurement: Hamilton Depression questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Mosadegh
Yazd University of Medical Sciences
Outcome results
None listed